Camber launches generic Aubagio
PISCATAWAY, N.J. – Camber Pharmaceuticals announced the addition of teriflunomide tablets to its current portfolio. Teriflunomide tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Teriflunomide tablets are available in 7 and 14 mg strengths and supplied in 30 count
